Replacing petroleum cracking with enzymatic conversion reduces environmental impact while maintaining alkene production yields.
Quinoa genes enable betalain synthesis in non-betalain plants, resolving extraction limits.
Cloning myxobacterial biosynthetic pathways into heterologous hosts overcomes fish oil supply limits and quality issues while boosting omega-3 yields.
Whole-cell biotransformation converts isoprenyl acetate to alpha-methylene-gamma-butyrolactone using alkane monooxygenase enzymes.
High-efficiency methylglyoxal reductases reduce metabolic burden on E. coli while boosting 1,2-propanediol fermentation yields.
Novel omega-3-desaturase enzyme converts C20 and C22 fatty acids in transgenic organisms, achieving high EPA and DHA yields.
Segmented siRNA strands bind and remove HSD17B13 transcripts, resolving lipid accumulation and inflammation caused by gene overexpression.
Engineered L-amino acid deaminase mutants catalyze L-valine conversion to alpha-ketoisovaleric acid with high transformation rates.
Aldehyde dehydrogenase converts 5-formyl-2-furancarboxylic acid to FDCA, eliminating toxic catalysts and harsh reaction conditions.
Reduced expression of downy mildew resistance proteins in sunflower plants provides durable disease protection without stunted growth.
Hydrogenase converts NADH to NAD+ via hydrogen generation, eliminating oxygen requirements that destabilize enzymes.
Nucleic acid inhibitors suppress metabolic enzymes to lower oxalate supersaturation, preventing kidney stone formation in non-primary hyperoxaluria.
Engineered ketoreductase enzymes convert racemic alcohols to optically pure products via stereoselective reduction.
Engineered microorganisms ferment carbon monoxide into acetone, bypassing costly sugar substrates used in traditional production.
Replacing polar amino acids with non-polar residues at position 113 increases soluble laccase yield by 50% while reducing misfolding.
Inhibiting pyruvate to lactate and oxaloacetate to succinate pathways reduces byproduct formation, lowering separation costs.
Luminescence and surface plasmon resonance assays measure AIF-CHCHD4 binding to screen compounds, resolving undetermined mitochondrial mechanisms.